Evidence map›Paper›PMID 38627369›Full record

ArticleCell death & disease2024

Mucopolysaccharidosis type II zebrafish model exhibits early impaired proteasomal-mediated degradation of the axon guidance receptor Dcc.

Rosa Manzoli, Lorenzo Badenetti, Matteo Bruzzone, Maria Carla Macario, Michela Rubin, Marco Dal Maschio, Antonella Roveri, Enrico Moro

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Rosa ManzoliDepartment of Molecular Medicine, University of Padova, 35121, Padova, Italy. rosa.manzoli@unipd.it.ORCID 0009-0000-4505-0261
Lorenzo BadenettiDepartment of Molecular Medicine, University of Padova, 35121, Padova, Italy.
Matteo BruzzoneDepartment of Biomedical Sciences, University of Padova, 35121, Padova, Italy.ORCID 0000-0001-7683-8107
Maria Carla MacarioDepartment of Molecular Medicine, University of Padova, 35121, Padova, Italy.
Michela RubinDepartment of Molecular Medicine, University of Padova, 35121, Padova, Italy.
Marco Dal MaschioDepartment of Biomedical Sciences, University of Padova, 35121, Padova, Italy.
Antonella RoveriDepartment of Molecular Medicine, University of Padova, 35121, Padova, Italy.ORCID 0000-0002-3252-0559
Enrico MoroDepartment of Molecular Medicine, University of Padova, 35121, Padova, Italy. enrico.moro.1@unipd.it.ORCID 0000-0003-3166-8102
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most of the patients affected by neuronopathic forms of Mucopolysaccharidosis type II (MPS II), a rare lysosomal storage disorder caused by defects in iduronate-2-sulfatase (IDS) activity, exhibit early neurological defects associated with white matter lesions and progressive behavioural abnormalities. While neuronal degeneration has been largely described in experimental models and human patients, more subtle neuronal pathogenic defects remain still underexplored. In this work, we discovered that the axon guidance receptor Deleted in Colorectal Cancer (Dcc) is significantly dysregulated in the brain of ids mutant zebrafish since embryonic stages. In addition, thanks to the establishment of neuronal-enriched primary cell cultures, we identified defective proteasomal degradation as one of the main pathways underlying Dcc upregulation in ids mutant conditions. Furthermore, ids mutant fish-derived primary neurons displayed higher levels of polyubiquitinated proteins and P62, suggesting a wider defect in protein degradation. Finally, we show that ids mutant larvae display an atypical response to anxiety-inducing stimuli, hence mimicking one of the characteristic features of MPS II patients. Our study provides an additional relevant frame to MPS II pathogenesis, supporting the concept that multiple developmental defects concur with early childhood behavioural abnormalities.

Indexed as

Iduronate SulfataseMucopolysaccharidosis IINervous System DiseasesAnimalsAxon GuidanceBrainDCC ReceptorZebrafishZebrafish Proteinsdcc protein, zebrafishDCC ReceptorIduronate SulfataseZebrafish Proteins

Identifiers

PMID38627369
PMCPMC11021486
OpenAlexW4394840711

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.